High-Throughput Screening Market by Product & Service (Consumables, Instruments, Services), Screening Size (12-well Format, 1536-well Format, 24-well Format), Technology, Application, End User - Global Forecast 2024-2030

High-Throughput Screening Market by Product & Service (Consumables, Instruments, Services), Screening Size (12-well Format, 1536-well Format, 24-well Format), Technology, Application, End User - Global Forecast 2024-2030

The High-Throughput Screening Market size was estimated at USD 23.05 billion in 2023 and expected to reach USD 26.09 billion in 2024, at a CAGR 13.67% to reach USD 56.53 billion by 2030.

High throughput screening is a mode of scientific experimentation that comprises screening large compound libraries for activity against biological targets via automation, miniaturized assays, and large-scale data analysis. It involves the rapid testing and analysis of many samples, enabling researchers to evaluate various compounds' effectiveness, selectivity, and potential toxicity. The primary applications of HTS are drug discovery and development in pharmaceutical and biotechnology companies, along with academic research laboratories. The rise in investment by governments and private organizations globally towards research and development activities fuels the growth of this market segment. Advances in computational biology enable researchers to analyze massive amounts of data generated by HTS systems more efficiently, which has significantly driven the market growth. However, high initial setup costs related to equipment procurement and maintenance and complexities related to data interpretation may hamper the market expansion. Expanding applications of HTS in different sectors, such as agrochemicals and environmental monitoring, will create a lucrative market opportunity in the forecasted period.

Regional Insights

The Americas experienced significant growth in high throughput screening market due to several government initiatives, patents for innovative technologies, and collaborative activities with industry partners to facilitate drug discovery through HTS. Within EU countries, HTS is being supported through initiatives funded by the European Commission research program towards advancing scientific breakthroughs and rising research and development activities by the key market vendors to optimize healthcare solutions. The Middle East and African region represents a growing market for HTS, driven mainly by investments in infrastructure development by governments seeking to improve local biotechnology capabilities. The Asia-Pacific region has observed a developing landscape due to government support by investing heavily in life sciences and pharmaceutical research and government-supported HTS advancement through funding programs such as the Japan Agency for Medical Research and Development (AMED). The rapidly growing pharmaceutical industry, fueled by strong government support in healthcare initiatives and innovation in drug discovery by providing access to HTS facilities at academic institutions, contributed to the market growth in the APAC region.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the High-Throughput Screening Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Growing adoption of open innovation models in biotechnology and pharmaceutical companies
Rising applications in stem cell research

Market Restraints

High cost associated with the equipment procurement and maintenance

Market Opportunities

Increasing investment in R&D by pharmaceutical & Government authorities
Technological advancements high throughput screening

Market Challenges

Dearth of skilled operators coupled with complexities related to data interpretation

Market Segmentation Analysis

Product & Service: Proliferating use of software in the HTS process to manage vast amounts of raw data
Technology: Adoption of cell-based assay technologies to get biologically relevant data for the drug discovery process
Screening Size: Utilization of 96-well format for increase in cell based studies
Application: Extensive utilization of the HTS process in drug discovery to identify compounds with pharmacological or biological activity
End User: Penetration of HTS technology in pharmaceutical & biotechnology companies for rapid development of novel therapeutics

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the High-Throughput Screening Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the High-Throughput Screening Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Axxam And Promega Announce Agreement To Develop Smart Assays For Drug Discovery Services

Axxam and Promega Corporation have signed an agreement to develop smart assays for drug discovery, utilizing high-throughput screening technology. This agreement leverages Promega's expertise in assay development and combines it with Axxam's high-throughput capabilities, resulting in a more efficient and cost-effective drug discovery process.

Charles River Laboratories Acquires SAMDI Tech

Charles River Laboratories has acquired Samdi Tech to enhance CRL's product suite and expand its range of services, allowing customers to access novel technologies for improved drug discovery. Samdi Tech's advanced automated systems are specifically designed to accelerate the screening and analysis of drug compounds, resulting in faster and more accurate results.

Particle Works Launches ALiS – An Automated and High-Throughput Platform for LNP Formulation Screening

Particle Works has introduced ALIS, a high-throughput platform designed specifically for LNP formulation in High-Throughput Screening. This innovative platform offers customized formulae with various properties, including size distribution, polydispersity index, and zeta potential. Researchers can expect reduced costs and accelerated drug discovery processes by leveraging ALIS.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the High-Throughput Screening Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the High-Throughput Screening Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aurora Biomed Inc., AXXAM S.p.A., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BMG LABTECH GmbH, Charles River Laboratories International, Inc., Corning Incorporated, Danaher Corporation, DIANA Biotechnologies, a.s., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Hamilton Company, IRBM S.p.A., Lonza Group AG, Luminex Corporation, Merck KGaA, Molecular Devices, LLC, NanoTemper Technologies GmbH, PerkinElmer, Inc., Promega Corporation, Reprocell Inc., SYGNATURE DISCOVERY LIMITED, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the High-Throughput Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product & Service
Consumables
Laboratory Equipment
Reagents & Assay Kits
Instruments
Detection Systems
Liquid Handling Systems
Services
Software
Screening Size
12-well Format
1536-well Format
24-well Format
384-well Format
48-well Format
6-well Format
96-well Format
Technology
Cell-Based Assays
2D Cell Culture
3D Cell Culture
Scaffold-Based Technology
Hydrogels
Alginate & Agarose
Animal-Derived Hydrogels
Collagen
Matrigel
Synthetic Hydrogels
Inert Matrix & Solid Scaffolds
Micropatterned Surfaces
Scaffold-Free Technology
Hanging-Drop Plates
Ultra-Low Binding Plates
Perfusion Cell Culture
Reporter-Based Assays
Lab-on-a-Chip Technology
Label-Free Technology
Application
Biochemical Screening
Drug Discovery
Life Sciences Research
End User
Academic & Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year